These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 22333159)
1. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China. Han J; Yong B; Luo C; Tan P; Peng T; Shen J World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma. Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480 [TBL] [Abstract][Full Text] [Related]
3. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma. Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412 [TBL] [Abstract][Full Text] [Related]
4. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis. Gu R; Sun Y J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708 [TBL] [Abstract][Full Text] [Related]
5. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma. Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345 [TBL] [Abstract][Full Text] [Related]
6. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma. Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP Oncology; 1996; 53(4):275-80. PubMed ID: 8692530 [TBL] [Abstract][Full Text] [Related]
7. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival. Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470 [TBL] [Abstract][Full Text] [Related]
8. Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma. Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma. Yang Q; Chen T; Yao Z; Zhang X World J Surg Oncol; 2020 Jan; 18(1):24. PubMed ID: 32000789 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma. Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949 [TBL] [Abstract][Full Text] [Related]
11. Serum Alkaline Phosphatase Predicts Poor Disease-Free Survival in Patients Receiving Radical Gastrectomy. Wu YJ; Wang Y; Qin R; Cao ZY; Zhao HZ; Du XH; Yang B Med Sci Monit; 2018 Dec; 24():9073-9080. PubMed ID: 30550533 [TBL] [Abstract][Full Text] [Related]
12. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience. Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627 [TBL] [Abstract][Full Text] [Related]
14. Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma. Cao LL; Chen Z; Yue Z; Pei L; Jia M; Wang H; Li T J Clin Lab Anal; 2020 May; 34(5):e23189. PubMed ID: 31916312 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma. Li Z; Liao Q; Wu Y; Liao M; Hao Y; Zhang S; Song S; Li B; Zhang YD Pathol Oncol Res; 2012 Jul; 18(3):657-61. PubMed ID: 22215309 [TBL] [Abstract][Full Text] [Related]
16. A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG. Flores RJ; Kelly AJ; Li Y; Nakka M; Barkauskas DA; Krailo M; Wang LL; Perlaky L; Lau CC; Hicks MJ; Man TK Cancer; 2017 Jan; 123(1):144-154. PubMed ID: 27529817 [TBL] [Abstract][Full Text] [Related]
17. XB130 expression in human osteosarcoma: a clinical and experimental study. Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762 [TBL] [Abstract][Full Text] [Related]
18. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis. Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325 [TBL] [Abstract][Full Text] [Related]
19. Correlation between the changes of serum COX 2, APE1, VEGF, TGF-β and TSGF levels and prognosis in patients with osteosarcoma before and after treatment. Zhang Q; Dong G; Wang F; Ding W J Cancer Res Ther; 2020; 16(2):335-342. PubMed ID: 32474521 [TBL] [Abstract][Full Text] [Related]
20. Strong expression of paired-like homeodomain transcription factor 1 (PITX1) is associated with a favorable outcome in human osteosarcoma. Kong G; Liu Z; Wu K; Zhang Y; Deng Z; Feng W; Chen S; Wang H Tumour Biol; 2015 Sep; 36(10):7735-41. PubMed ID: 25936343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]